Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miyuki Azuma

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Plos One|August 4, 2017
Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environmentAlessandra De Riva, Maja Wållberg, Francesca Ronchi, et al.
Journal of Hepatology|March 1, 2016
Effector T cell function rather than survival determines extent and duration of hepatitis in miceMichelle Vo, Lauren E Holz, Yik Chun Wong, et al.
European Journal of Immunology|September 30, 2003
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responsesFumihiko Tsushima, Hideyuki Iwai, Noriko Otsuki, et al.
The Journal of Experimental Medicine|July 9, 2003
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitisAlan D Salama, Tanuja Chitnis, Jaime Imitola, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 18, 2004
Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allograftsNoritaka Koga, Jun-ichi Suzuki, Hisanori Kosuge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2011
Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivoNienke van der Werf, Stephen A Redpath, Alexander T Phythian-Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Expression of programmed death 1 ligands by murine T cells and APCTomohide Yamazaki, Hisaya Akiba, Hideyuki Iwai, et al.
Cancer Research|November 10, 2012
RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemiaBenjamin Joachim Schmiedel, Carolin Andrea Scheible, Tina Nuebling, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2014
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host diseaseHideaki Fujiwara, Yoshinobu Maeda, Koichiro Kobayashi, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Plos One|August 4, 2017
Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environmentAlessandra De Riva, Maja Wållberg, Francesca Ronchi, et al.
Journal of Hepatology|March 1, 2016
Effector T cell function rather than survival determines extent and duration of hepatitis in miceMichelle Vo, Lauren E Holz, Yik Chun Wong, et al.
European Journal of Immunology|September 30, 2003
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responsesFumihiko Tsushima, Hideyuki Iwai, Noriko Otsuki, et al.
The Journal of Experimental Medicine|July 9, 2003
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitisAlan D Salama, Tanuja Chitnis, Jaime Imitola, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 18, 2004
Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allograftsNoritaka Koga, Jun-ichi Suzuki, Hisanori Kosuge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2011
Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivoNienke van der Werf, Stephen A Redpath, Alexander T Phythian-Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Expression of programmed death 1 ligands by murine T cells and APCTomohide Yamazaki, Hisaya Akiba, Hideyuki Iwai, et al.
Cancer Research|November 10, 2012
RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemiaBenjamin Joachim Schmiedel, Carolin Andrea Scheible, Tina Nuebling, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2014
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host diseaseHideaki Fujiwara, Yoshinobu Maeda, Koichiro Kobayashi, et al.
Pageof 16